100
Participants
Start Date
August 29, 2025
Primary Completion Date
September 29, 2026
Study Completion Date
September 29, 2026
BXCL501 (dexmedetomidine HCl)
BXCL501 (dexmedetomidine HCl) taken sublingually (under the tongue) in the ED and at bedtime over 2 weeks.
Placebo
Placebo taken sublingually (under the tongue) in the ED and at bedtime over 2 weeks.
UVA University Hospital, Charlottesville
University of Florida College of Medicine - Jacksonville, Jacksonville
Washington University in St. Louis, St Louis
Rhode Island Hospital, Providence
The Miriam Hospital, Providence
United States Department of Defense
FED
Mclean Hospital
OTHER
Washington University School of Medicine
OTHER
University of Florida
OTHER
Rhode Island Hospital
OTHER
Vanderbilt University School of Medicine
OTHER
Walter Reed Army Institute of Research (WRAIR)
FED
University of North Carolina, Chapel Hill
OTHER